Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors
Crossref DOI link: https://doi.org/10.1007/s40261-016-0463-2
Published Online: 2016-09-24
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nerich, Virginie
Fleck, Camille
Chaigneau, Loïc
Isambert, Nicolas
Borg, Christophe
Kalbacher, Elsa
Jary, Marine
Simon, Pauline
Pivot, Xavier
Blay, Jean-Yves
Limat, Samuel
License valid from 2016-09-24